Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composition for treating chronic laryngitis

A technology for chronic laryngitis and a composition is applied in the field of pharmaceutical compositions for the treatment of chronic laryngitis and the preparation thereof, and can solve the problems of insufficient organic coordination, inconsistent diagnosis and curative effect judgment standards, and influence on objective evaluation of curative effects.

Inactive Publication Date: 2017-03-29
JINAN HAOYU QINGTIAN PHARMA TECH CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

According to the analysis of TCM literature reports in recent years, the diagnosis and curative effect judging standards of chronic laryngitis are not unified, and there is a lack of objective monitoring indicators and control groups, which affect the objective evaluation of curative effect; Long-term curative effect observation, and the organic cooperation between various therapies is not enough, if combined application, it can better shorten the course of treatment and improve the curative effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine composition for treating chronic laryngitis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Embodiment 1: the pharmaceutical composition for the treatment of chronic laryngitis and preparation method thereof

[0033] The composition and parts by weight of the raw materials of the pharmaceutical composition for treating chronic laryngitis are: 28g of anisodine, 1285g of blueberry, and 843g of moss moss;

[0034] Preparation:

[0035](1) According to the ratio of raw materials, take anisodine, blueberry and moss moss, mix them evenly, use ethanol with a concentration of 34% by weight as a solvent, and extract by warm soaking at 28°C. The number of extractions is 13 times, and each extraction The time is 26 hours, the amount of solvent used each time is 33 times of the total weight of the crude drug, filtered to obtain medicinal residue A and extract A, the extract A recovers ethanol, concentrates to a relative density of 1.03, filters, and the liquid passes through FU- 01 macroporous adsorption resin column, elute with water first, then elute the FU-01 macropor...

Embodiment 2

[0038] Embodiment 2: the pharmaceutical composition for the treatment of chronic laryngitis and preparation method thereof

[0039] The composition and parts by weight of the raw materials of the pharmaceutical composition for treating chronic laryngitis are: 26g of anisodine, 1290g of blueberry, and 840g of moss moss;

[0040] Preparation:

[0041] (1) According to the ratio of raw materials, take anisodine, blueberry and moss moss, mix them evenly, use ethanol with a concentration of 34% by weight as a solvent, and extract by warm soaking at 28°C. The number of extractions is 13 times, and each extraction The time is 26 hours, the amount of solvent used each time is 33 times of the total weight of the crude drug, filtered to obtain medicinal residue A and extract A, the extract A recovers ethanol, concentrates to a relative density of 1.03, filters, and the liquid passes through FU- 01 macroporous adsorption resin column, elute with water first, then elute the FU-01 macropo...

Embodiment 3

[0044] Embodiment 3: the pharmaceutical composition for the treatment of chronic laryngitis and preparation method thereof

[0045] The composition and parts by weight of the raw material drug of the pharmaceutical composition for treating chronic laryngitis are: 30g of anisodine, 1280g of blueberry, and 846g of moss moss;

[0046] Preparation:

[0047] (1) According to the ratio of raw materials, take anisodine, blueberry and moss moss, mix them evenly, use ethanol with a concentration of 34% by weight as a solvent, and extract by warm soaking at 28°C. The number of extractions is 13 times, and each extraction The time is 26 hours, the amount of solvent used each time is 33 times of the total weight of the crude drug, filtered to obtain medicinal residue A and extract A, the extract A recovers ethanol, concentrates to a relative density of 1.03, filters, and the liquid passes through FU- 01 macroporous adsorption resin column, elute with water first, then elute the FU-01 mac...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine composition for treating chronic laryngitis and a preparation method thereof. The medicine composition is prepared by proportioning raw material medicines including anisodine, lonicera caerulea and climacium dendroides. The medicine composition for treating the chronic laryngitis can be prepared to be of various agent forms and has a remarkable effect of treating the chronic laryngitis.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to a pharmaceutical composition for treating chronic laryngitis and a preparation method thereof. Background technique [0002] Chronic laryngitis, also known as chronic non-specific laryngitis, is a chronic inflammation of the laryngeal mucosa. It is mainly caused by repeated episodes of acute laryngitis that are not treated in time and become chronic, or caused by long-term improper and excessive voice use. It manifests as chronic congestion and swelling of the laryngeal mucosa, lymphocyte infiltration, increased glandular secretion, followed by hyperplasia of connective tissue, mucosal hypertrophy, dilation of blood vessels on the surface of the vocal cords, and subepithelial exudation, etc. In severe cases, there are granular protrusions or polypoid changes on the surface of the mucosa . The main symptoms are hoarseness, short-lasting phonation...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/355A61P11/04A61K31/439
CPCA61K36/355A61K31/439A61K36/10A61K2236/333A61K2236/39A61K2236/51A61K2236/55
Inventor 不公告发明人
Owner JINAN HAOYU QINGTIAN PHARMA TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com